General Information of the Protein
Protein ID
PT01896
Protein Name
Bone morphogenetic protein 1
Secondarily
Protein Name
Mammalian tolloid protein
Procollagen C-proteinase
Gene Name
BMP1
Secondarily
Gene Name
PCOLC
Sequence
MPGVARLPLLLGLLLLPRPGRPLDLADYTYDLAEEDDSEPLNYKDPCKAAAFLGDIALDEEDLRAFQVQQAVDLRRHTARKSSIKAAVPGNTSTPSCQSTNGQPQRGACGRWRGRSRSRRAATSRPERVWPDGVIPFVIGGNFTGSQRAVFRQAMRHWEKHTCVTFLERTDEDSYIVFTYRPCGCCSYVGRRGGGPQAISIGKNCDKFGIVVHELGHVVGFWHEHTRPDRDRHVSIVRENIQPGQEYNFLKMEPQEVESLGETYDFDSIMHYARNTFSRGIFLDTIVPKYEVNGVKPPIGQRTRLSKGDIAQARKLYKCPACGETLQDSTGNFSSPEYPNGYSAHMHCVWRISVTPGEKIILNFTSLDLYRSRLCWYDYVEVRDGFWRKAPLRGRFCGSKLPEPIVSTDSRLWVEFRSSSNWVGKGFFAVYEAICGGDVKKDYGHIQSPNYPDDYRPSKVCIWRIQVSEGFHVGLTFQSFEIERHDSCAYDYLEVRDGHSESSTLIGRYCGYEKPDDIKSTSSRLWLKFVSDGSINKAGFAVNFFKEVDECSRPNRGGCEQRCLNTLGSYKCSCDPGYELAPDKRRCEAACGGFLTKLNGSITSPGWPKEYPPNKNCIWQLVAPTQYRISLQFDFFETEGNDVCKYDFVEVRSGLTADSKLHGKFCGSEKPEVITSQYNNMRVEFKSDNTVSKKGFKAHFFSDKDECSKDNGGCQQDCVNTFGSYECQCRSGFVLHDNKHDCKEAGCDHKVTSTSGTITSPNWPDKYPSKKECTWAISSTPGHRVKLTFMEMDIESQPECAYDHLEVFDGRDAKAPVLGRFCGSKKPEPVLATGSRMFLRFYSDNSVQRKGFQASHATECGGQVRADVKTKDLYSHAQFGDNNYPGGVDCEWVIVAEEGYGVELVFQTFEVEEETDCGYDYMELFDGYDSTAPRLGRYCGSGPPEEVYSAGDSVLVKFHSDDTITKKGFHLRYTSTKFQDTLHSRK
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Protease
>
Metallo protease
>
Metallo protease MAM clan
>
Metallo protease M12A subfamily
Function
Metalloprotease that plays key roles in regulating the formation of the extracellular matrix (ECM) via processing of various precursor proteins into mature functional enzymes or structural proteins (PubMed:33206546). Thereby participates in several developmental and physiological processes such as cartilage and bone formation, muscle growth and homeostasis, wound healing and tissue repair (PubMed:33169406, PubMed:32636307). Roles in ECM formation include cleavage of the C-terminal propeptides from procollagens such as procollagen I, II and III or the proteolytic activation of the enzyme lysyl oxidase LOX, necessary to formation of covalent cross-links in collagen and elastic fibers (PubMed:31152061, PubMed:33206546). Additional substrates include matricellular thrombospondin-1/THBS1 whose cleavage leads to cell adhesion disruption and TGF-beta activation (PubMed:32636307).
    Show/Hide
Uniprot ID
Primary ID:
P13497

Secondarily ID:
A8K6F5
B2RN46
D3DSR0
Q13292
Q13872
Q14874
Q99421
Q99422
Q99423
Q9UL38
    Show/Hide
Ensembl ID
ENSG00000168487
HGNC ID
HGNC:1067
Subcellular Location
Golgi apparatus
Trans-Golgi network
Secreted
Extracellular space
Extracellular matrix
Secreted
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000011 , CHO
Compound ID Compound Name Compound Formula
CP0104223
[3-ethoxy-5-[5-[[[(2R)-2-[(1R)-1-[formyl(hydroxy)amino]propyl]heptanoyl]amino]methylcarbamoyl]furan-2-yl]phenyl]phosphonic acid
   Show/Hide
C25H36N3O9P
 1
1
IC50 < 1 nM
   TI
   LI
   LO
   TS
CP0126696
(2S)-2-[[2-ethoxy-4-[5-[[[(2R)-2-[(1R)-1-[formyl(hydroxy)amino]propyl]heptanoyl]amino]methylcarbamoyl]furan-2-yl]benzoyl]amino]butanedioic acid
   Show/Hide
C30H40N4O11
 1
1
IC50 < 1 nM
   TI
   LI
   LO
   TS
CP0392436
(2S)-2-[[3-ethoxy-5-[5-[[[(2R)-2-[(1R)-1-[formyl(hydroxy)amino]propyl]heptanoyl]amino]methylcarbamoyl]furan-2-yl]benzoyl]amino]butanedioic acid
   Show/Hide
C30H40N4O11
 1
1
IC50 < 1 nM
   TI
   LI
   LO
   TS
CP0413964
2-ethoxy-4-[5-[[[(2R)-2-[(1R)-1-[formyl(hydroxy)amino]propyl]heptanoyl]amino]methylcarbamoyl]furan-2-yl]benzoic acid
   Show/Hide
C26H35N3O8
 1
1
IC50 < 1 nM
   TI
   LI
   LO
   TS
CP0446430
5-(3-ethoxyphenyl)-N-[[[(2R)-2-[[formyl(hydroxy)amino]methyl]heptanoyl]amino]methyl]furan-2-carboxamide
   Show/Hide
C23H31N3O6
 1
1
IC50 = 1 nM
   TI
   LI
   LO
   TS
CP0446432
4-[5-[[[(2R)-2-[[formyl(hydroxy)amino]methyl]heptanoyl]amino]methylcarbamoyl]furan-2-yl]benzoic acid
   Show/Hide
C22H27N3O7
 1
1
IC50 = 1 nM
   TI
   LI
   LO
   TS
CP0468823
3-ethoxy-5-[5-[[[(2R)-2-[(1R)-1-[formyl(hydroxy)amino]propyl]heptanoyl]amino]methylcarbamoyl]furan-2-yl]benzoic acid
   Show/Hide
C26H35N3O8
 1
1
IC50 < 1 nM
   TI
   LI
   LO
   TS
CP0472937
[2-ethoxy-4-[5-[[[(2R)-2-[(1R)-1-[formyl(hydroxy)amino]propyl]heptanoyl]amino]methylcarbamoyl]furan-2-yl]phenyl]phosphonic acid
   Show/Hide
C25H36N3O9P
 1
1
IC50 < 1 nM
   TI
   LI
   LO
   TS
CP0467262
(3R)-6-cyclohexyl-3-[3-({[(3,4-dimethoxyphenyl)sulfonyl]-amino}carbonyl)-1,2,4-oxadiazol-5-yl]-N-hydroxyhexanamide
   Show/Hide
C23H32N4O8S
 1
1
IC50 = 1.8 nM
   TI
   LI
   LO
   TS
CP0444379
(3R)-6-cyclohexyl-N-hydroxy-3-[3-(4-pyridinyl)-1,2,4-oxadiazol-5-yl]hexanamide
   Show/Hide
C19H26N4O3
 1
1
IC50 = 2 nM
   TI
   LI
   LO
   TS
CP0145177
(3R)-6-cyclohexyl-N-hydroxy-3-{3-[1-(methylsulfonyl)-4-piperidinyl]-1,2,4-oxadiazol-5-yl}hexanamide
   Show/Hide
C21H37N5O5S
 1
1
IC50 = 3 nM
   TI
   LI
   LO
   TS
CP0427386
(3R)-3-(3-{[acetyl(methyl)amino]methyl}-1,2,4-oxadiazol-5-yl)-6-cyclohexyl-Nhydroxyhexanamide
   Show/Hide
C18H30N4O4
 1
1
IC50 = 3 nM
   TI
   LI
   LO
   TS
CP0439783
(3R)-6-cyclohexyl-N-hydroxy-3-(3-{4-[(methylsulfonyl)amino]phenyl}-1,2,4-oxadiazol-5-yl)hexanamide
   Show/Hide
C21H30N4O5S
 1
1
IC50 = 3 nM
   TI
   LI
   LO
   TS
CP0528617
(3R)-6-cyclohexyl-N-hydroxy-3-[3-(4-morpholinylmethyl)-1,2,4-oxadiazol-5-yl]hexanamide
   Show/Hide
C19H32N4O4
 1
1
IC50 = 5 nM
   TI
   LI
   LO
   TS
CP0052404
(3R)-6-cyclohexyl-N-hydroxy-3-[3-(3-pyridinylmethyl)-1,2,4-oxadiazol-5-yl]hexanamide
   Show/Hide
C20H28N4O3
 1
1
IC50 = 6 nM
   TI
   LI
   LO
   TS
CP0052406
2-(5-{(1R)-4-cyclohexyl-1-[2-(hydroxyamino)-2-oxoethyl]butyl}-1,2,4-oxadiazol-3-yl)isonicotinic acid
   Show/Hide
C20H26N4O5
 1
1
IC50 = 6 nM
   TI
   LI
   LO
   TS
CP0379094
(3R)-3-{3-[(cyclobutylamino)methyl]-1,2,4-oxadiazol-5-yl}-6-cyclohexyl-Nhydroxyhexanamide
   Show/Hide
C19H32N4O3
 1
1
IC50 = 6 nM
   TI
   LI
   LO
   TS
CP0379100
3-(5-{(1R)-4-cyclohexyl-1-[2-(hydroxyamino)-2-oxoethyl]butyl}-1,2,4-oxadiazol-3-yl)benzoic acid
   Show/Hide
C21H27N3O5
 1
1
IC50 = 6 nM
   TI
   LI
   LO
   TS
CP0501053
(3R)-6-cyclohexyl-3-{3-[(cyclopropylamino)methyl]-1,2,4-oxadiazol-5-yl}-Nhydroxyhexanamide
   Show/Hide
C18H30N4O3
 1
1
IC50 = 6 nM
   TI
   LI
   LO
   TS
CP0528618
(3R)-6-cyclohexyl-N-hydroxy-3-[3-(2-pyridinylmethyl)-1,2,4-oxadiazol-5-yl]hexanamide
   Show/Hide
C20H28N4O3
 1
1
IC50 = 6 nM
   TI
   LI
   LO
   TS
CP0052405
(3R)-6-cyclohexyl-N-hydroxy-3-(3-{[(phenylsulfonyl)amino]carbonyl}-1,2,4-oxadiazol-5-yl)hexanamide
   Show/Hide
C21H28N4O6S
 1
1
IC50 = 7 nM
   TI
   LI
   LO
   TS
CP0052401
(3R)-6-cyclohexyl-N-hydroxy-3-(3-{[(2-hydroxy-1,1-dimethylethyl)amino]methyl}-1,2,4-oxadiazol-5-yl)hexanamide
   Show/Hide
C19H34N4O4
 1
1
IC50 = 8 nM
   TI
   LI
   LO
   TS
CP0427387
(3R)-6-cyclohexyl-N-hydroxy-3-{3-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]-1,2,4-oxadiazol-5-yl}hexanamide
   Show/Hide
C19H33N5O3
 1
1
IC50 = 8 nM
   TI
   LI
   LO
   TS
CP0446431
3-[5-[[[(2R)-2-[[formyl(hydroxy)amino]methyl]heptanoyl]amino]methylcarbamoyl]furan-2-yl]benzoic acid
   Show/Hide
C22H27N3O7
 1
1
IC50 = 8 nM
   TI
   LI
   LO
   TS
CP0128115
(R)-5-(6-cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl)-N,N-dimethyl-1,2,4-oxadiazole-3-carboxamide
   Show/Hide
C17H28N4O4
 1
1
IC50 = 10 nM
   TI
   LI
   LO
   TS
CP0052400
(3R)-6-cyclohexyl-3-[3-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-1,2,4-oxadiazol-5-yl]-N-hydroxyhexanamide
   Show/Hide
C18H25N5O5
 1
1
IC50 = 10 nM
   TI
   LI
   LO
   TS
CP0427191
(3R)-3-{3-[(tert-butylamino)methyl]-1,2,4-oxadiazol-5-yl}-6-cyclohexyl-Nhydroxyhexanamide
   Show/Hide
C19H34N4O3
 1
1
IC50 = 10 nM
   TI
   LI
   LO
   TS
CP0052399
(3R)-6-cyclohexyl-N-hydroxy-3-(3-{[(methylsulfonyl)amino]-methyl}-1,2,4-oxadiazol-5-yl)hexanamide
   Show/Hide
C16H28N4O5S
 1
1
IC50 = 11 nM
   TI
   LI
   LO
   TS
CP0439782
(3R)-6-cyclohexyl-N-hydroxy-3-{3-[6-(methylamino)-3-pyridinyl]-1,2,4-oxadiazol-5-yl}hexanamide
   Show/Hide
C20H29N5O3
 1
1
IC50 = 13 nM
   TI
   LI
   LO
   TS
CP0444377
(3R)-6-cyclohexyl-N-hydroxy-3-{3-[(4-hydroxy-1-piperidinyl)methyl]-1,2,4-oxadiazol-5-yl}hexanamide
   Show/Hide
C20H34N4O4
 1
1
IC50 = 13 nM
   TI
   LI
   LO
   TS
CP0379099
(3R)-6-cyclohexyl-N-hydroxy-3-[3-(5-pyrimidinyl)-1,2,4-oxadiazol-5-yl]hexanamide
   Show/Hide
C18H25N5O3
 1
1
IC50 = 14 nM
   TI
   LI
   LO
   TS
CP0428682
(3R)-6-cyclohexyl-N-hydroxy-3-[3-(2-pyrazinyl)-1,2,4-oxadiazol-5-yl]hexanamide
   Show/Hide
C18H25N5O3
 1
1
IC50 = 14 nM
   TI
   LI
   LO
   TS
CP0554272
(3R)-6-cyclohexyl-N-hydroxy-3-[3-({[(4-methylphenyl)sulfonyl]amino}-carbonyl)-1,2,4-oxadiazol-5-yl]hexanamide
   Show/Hide
C22H30N4O6S
 1
1
IC50 = 14 nM
   TI
   LI
   LO
   TS
CP0532158
(3R)-6-cyclohexyl-3-[3-(1,1-dioxido-2-isothiazolidinyl)-1,2,4-oxadiazol-5-yl]-Nhydroxyhexanamide
   Show/Hide
C18H30N4O5S
 1
1
IC50 = 15 nM
   TI
   LI
   LO
   TS
CP0508884
(R)-2-(6-cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl)-5-methyloxazole-4-carboxamide
   Show/Hide
C17H27N3O4
 1
1
IC50 = 17 nM
   TI
   LI
   LO
   TS
CP0521462
(R)-2-(6-cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl)-N,N,5-trimethyloxazole-4-carboxamide
   Show/Hide
C19H31N3O4
 1
1
IC50 = 17 nM
   TI
   LI
   LO
   TS
CP0460078
5-(5-{(1R)-4-cyclohexyl-1-[2-(hydroxyamino)-2-oxoethyl]butyl}-1,2,4-oxadiazol-3-yl)nicotinic acid
   Show/Hide
C20H26N4O5
 1
1
IC50 = 17 nM
   TI
   LI
   LO
   TS
CP0462758
2-(5-{(1R)-4-cyclohexyl-1-[2-(hydroxyamino)-2-oxoethyl]butyl}-1,2,4-oxadiazol-3-yl)isonicotinamide
   Show/Hide
C20H27N5O4
 1
1
IC50 = 17 nM
   TI
   LI
   LO
   TS
CP0528619
2-(5-{(1R)-4-cyclohexyl-1-[2-(hydroxyamino)-2-oxoethyl]butyl}-1,2,4-oxadiazol-3-yl)-N,N-dimethylisonicotinamide
   Show/Hide
C22H31N5O4
 1
1
IC50 = 17 nM
   TI
   LI
   LO
   TS
CP0554270
(3R)-6-cyclohexyl-N-hydroxy-3-[3-({[(4-methoxyphenyl)sulfonyl]amino}carbonyl)-1,2,4-oxadiazol-5-yl]hexanamide
   Show/Hide
C22H30N4O7S
 1
1
IC50 = 17 nM
   TI
   LI
   LO
   TS
CP0379098
(3R)-3-[3-(6-amino-3-pyridinyl)-1,2,4-oxadiazol-5-yl]-6-cyclohexyl-Nhydroxyhexanamide
   Show/Hide
C19H27N5O3
 1
1
IC50 = 18 nM
   TI
   LI
   LO
   TS
CP0379093
(3R)-3-{3-[(acetylamino)methyl]-1,2,4-oxadiazol-5-yl}-6-cyclohexyl-Nhydroxyhexanamide
   Show/Hide
C17H28N4O4
 1
1
IC50 = 19 nM
   TI
   LI
   LO
   TS
CP0554275
(3R)-6-cyclohexyl-N-hydroxy-3-(3-{2-[(methylsulfonyl)amino]ethyl}-1,2,4-oxadiazol-5-yl)hexanamide
   Show/Hide
C18H33N5O5S
 1
1
IC50 = 20 nM
   TI
   LI
   LO
   TS
CP0417140
N-[[[(2R)-2-[[formyl(hydroxy)amino]methyl]heptanoyl]amino]methyl]-5-(3-methoxyphenyl)furan-2-carboxamide
   Show/Hide
C22H29N3O6
 1
1
IC50 = 20 nM
   TI
   LI
   LO
   TS
CP0235360
(R)-5-(6-cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl)-N-isopropyl-1,2,4-oxadiazole-3-carboxamide
   Show/Hide
C18H30N4O4
 1
1
IC50 = 21 nM
   TI
   LI
   LO
   TS
CP0502181
(R)-2-(5-(6-cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl)-1,2,4-oxadiazole-3-carboxamido)acetic acid
   Show/Hide
C17H26N4O6
 1
1
IC50 = 21 nM
   TI
   LI
   LO
   TS
CP0427192
(3R)-6-cyclohexyl-3-{3-[(ethylamino)methyl]-1,2,4-oxadiazol-5-yl}-Nhydroxyhexanamide
   Show/Hide
C17H30N4O3
 1
1
IC50 = 21 nM
   TI
   LI
   LO
   TS
CP0509507
(3R)-6-cyclohexyl-N-hydroxy-3-(3-{[(isopropylsulfonyl)amino]methyl}-1,2,4-oxadiazol-5-yl)hexanamide
   Show/Hide
C18H32N4O5S
 1
1
IC50 = 21 nM
   TI
   LI
   LO
   TS
CP0379095
(3R)-6-cyclohexyl-N-hydroxy-3-{3-[(methylamino)methyl]-1,2,4-oxadiazol-5-yl}hexanamide
   Show/Hide
C16H28N4O3
 1
1
IC50 = 23 nM
   TI
   LI
   LO
   TS
CP0427388
(3R)-6-cyclohexyl-N-hydroxy-3-[3-(2-pyrimidinyl)-1,2,4-oxadiazol-5-yl]hexanamide
   Show/Hide
C18H25N5O3
 1
1
IC50 = 23 nM
   TI
   LI
   LO
   TS
CP0444380
(3R)-6-cyclohexyl-N-hydroxy-3-[3-(3-pyridinyl)-1,2,4-oxadiazol-5-yl]hexanamide
   Show/Hide
C19H26N4O3
 1
1
IC50 = 23 nM
   TI
   LI
   LO
   TS
CP0460077
(3R)-6-cyclohexyl-N-hydroxy-3-[3-(1-pyrrolidinylmethyl)-1,2,4-oxadiazol-5-yl]hexanamide
   Show/Hide
C19H32N4O3
 1
1
IC50 = 24 nM
   TI
   LI
   LO
   TS
CP0130693
(R)-6-cyclohexyl-N-hydroxy-3-(3-(morpholine-4-carbonyl)-1,2,4-oxadiazol-5-yl)hexanamide
   Show/Hide
C19H30N4O5
 1
1
IC50 = 25 nM
   TI
   LI
   LO
   TS
CP0511168
(3R)-6-cyclohexyl-N-hydroxy-3-[3-(2-pyridinyl)-1,2,4-oxadiazol-5-yl]hexanamide
   Show/Hide
C19H26N4O3
 1
1
IC50 = 25 nM
   TI
   LI
   LO
   TS
CP0487911
N-[[[(2R)-2-[[formyl(hydroxy)amino]methyl]heptanoyl]amino]methyl]-5-phenylfuran-2-carboxamide
   Show/Hide
C21H27N3O5
 1
1
IC50 = 25 nM
   TI
   LI
   LO
   TS
CP0203299
(R)-6-cyclohexyl-N-hydroxy-3-(3-(piperidine-1-carbonyl)-1,2,4-oxadiazol-5-yl)hexanamide
   Show/Hide
C20H32N4O4
 1
1
IC50 = 26 nM
   TI
   LI
   LO
   TS
CP0427189
(3R)-6-cyclohexyl-N-hydroxy-3-(3-{[(phenylsulfonyl)amino]methyl}-1,2,4-oxadiazol-5-yl)hexanamide
   Show/Hide
C21H30N4O5S
 1
1
IC50 = 26 nM
   TI
   LI
   LO
   TS
CP0467263
(3R)-6-cyclohexyl-3-(3-{[(ethylsulfonyl)amino]methyl}-1,2,4-oxadiazol-5-yl)-Nhydroxyhexanamide
   Show/Hide
C17H30N4O5S
 1
1
IC50 = 26 nM
   TI
   LI
   LO
   TS
CP0532159
(3R)-6-cyclohexyl-N-hydroxy-3-(3-{[(3-pyridinylsulfonyl)amino]methyl}-1,2,4-oxadiazol-5-yl)hexanamide
   Show/Hide
C20H29N5O5S
 1
1
IC50 = 26 nM
   TI
   LI
   LO
   TS
CP0444378
(3R)-6-cyclohexyl-N-hydroxy-3-(3-{6-[(methylsulfonyl)amino]-3-pyridinyl}-1,2,4-oxadiazol-5-yl)hexanamide
   Show/Hide
C15H26N4O5S
 1
1
IC50 = 27 nM
   TI
   LI
   LO
   TS
CP0091027
(R)-5-(6-cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl)-N-methyl-1,2,4-oxadiazole-3-carboxamide
   Show/Hide
C16H26N4O4
 1
1
IC50 = 28 nM
   TI
   LI
   LO
   TS
CP0379096
(3R)-6-cyclohexyl-N-hydroxy-3-[3-(4-pyridinylmethyl)-1,2,4-oxadiazol-5-yl]hexanamide
   Show/Hide
C20H28N4O3
 1
1
IC50 = 28 nM
   TI
   LI
   LO
   TS
CP0501061
(3R)-6-cyclohexyl-3-{3-[6-(dimethylamino)-3-pyridinyl]-1,2,4-oxadiazol-5-yl}-Nhydroxyhexanamide
   Show/Hide
C21H31N5O3
 1
1
IC50 = 28 nM
   TI
   LI
   LO
   TS
CP0532161
(3R)-6-cyclohexyl-N-hydroxy-3-{3-[(isopropylamino)methyl]-1,2,4-oxadiazol-5-yl}hexanamide
   Show/Hide
C18H32N4O3
 1
1
IC50 = 29 nM
   TI
   LI
   LO
   TS
CP0427530
2-(5-{(1R)-4-cyclohexyl-1-[2-(hydroxyamino)-2-oxoethyl]butyl}-1,2,4-oxadiazol-3-yl)-N-methylisonicotinamide
   Show/Hide
C21H29N5O4
 1
1
IC50 = 30 nM
   TI
   LI
   LO
   TS
CP0528620
(3R)-6-cyclohexyl-N-hydroxy-3-[3-(6-methyl-3-pyridazinyl)-1,2,4-oxadiazol-5-yl]hexanamide
   Show/Hide
C19H27N5O3
 1
1
IC50 = 30 nM
   TI
   LI
   LO
   TS
CP0509494
(3R)-6-cyclohexyl-3-{3-[(dimethylamino)methyl]-1,2,4-oxadiazol-5-yl}-Nhydroxyhexanamide
   Show/Hide
C17H30N4O3
 1
1
IC50 = 31 nM
   TI
   LI
   LO
   TS
CP0274383
(R)-5-(6-cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl)-N-propyl-1,2,4-oxadiazole-3-carboxamide
   Show/Hide
C18H30N4O4
 1
1
IC50 = 32 nM
   TI
   LI
   LO
   TS
CP0379102
4-(5-{(1R)-4-cyclohexyl-1-[2-(hydroxyamino)-2-oxoethyl]butyl}-1,2,4-oxadiazol-3-yl)benzoic acid
   Show/Hide
C21H27N3O5
 1
1
IC50 = 32 nM
   TI
   LI
   LO
   TS
CP0417141
N-[[[(2R)-2-[(1R)-1-[formyl(hydroxy)amino]propyl]heptanoyl]amino]methyl]-5-phenylfuran-2-carboxamide
   Show/Hide
C23H31N3O5
 1
1
IC50 = 32 nM
   TI
   LI
   LO
   TS
CP0329408
(R)-5-(6-cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl)-N-(cyclopropylmethyl)-1,2,4-oxadiazole-3-carboxamide
   Show/Hide
C19H30N4O4
 1
1
IC50 = 33 nM
   TI
   LI
   LO
   TS
CP0464611
(3R)-6-cyclohexyl-3-[3-({[(4-fluorophenyl)sulfonyl]amino}carbonyl)-1,2,4-oxadiazol-5-yl]-N-hydroxyhexanamide
   Show/Hide
C21H27FN4O6S
 1
1
IC50 = 33 nM
   TI
   LI
   LO
   TS
CP0052407
(R)-ethyl 5-(6-cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl)-1,2,4-oxadiazole-3-carboxylate
   Show/Hide
C17H27N3O5
 1
1
IC50 = 36 nM
   TI
   LI
   LO
   TS
CP0329409
(R)-5-(6-cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl)-N-(pyridin-2-ylmethyl)-1,2,4-oxadiazole-3-carboxamide
   Show/Hide
C21H29N5O4
 1
1
IC50 = 37 nM
   TI
   LI
   LO
   TS
CP0379092
(3R)-6-cyclohexyl-N-hydroxy-3-(3-{[methyl(methylsulfonyl)amino]methyl}-1,2,4-oxadiazol-5-yl)hexanamide
   Show/Hide
C17H30N4O5S
 1
1
IC50 = 38 nM
   TI
   LI
   LO
   TS
CP0427193
(3R)-6-cyclohexyl-N-hydroxy-3-[3-(1H-pyrazol-4-yl)-1,2,4-oxadiazol-5-yl]hexanamide
   Show/Hide
C17H25N5O3
 1
1
IC50 = 39 nM
   TI
   LI
   LO
   TS
CP0332992
(R)-5-(6-cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl)-N-methyl-N-(pyridin-2-ylmethyl)-1,2,4-oxadiazole-3-carboxamide
   Show/Hide
C22H31N5O4
 1
1
IC50 = 40 nM
   TI
   LI
   LO
   TS
CP0324865
(R)-6-cyclohexyl-N-hydroxy-3-(3-(pyrrolidine-1-carbonyl)-1,2,4-oxadiazol-5-yl)hexanamide
   Show/Hide
C19H30N4O4
 1
1
IC50 = 43 nM
   TI
   LI
   LO
   TS
CP0052398
(3R)-6-cyclohexyl-N-hydroxy-3-(1,2,4-oxadiazol-5-yl)hexanamide
   Show/Hide
C15H24N4O4
 1
1
IC50 = 44 nM
   TI
   LI
   LO
   TS
CP0524369
(R)-2-(6-cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl)-N,N-dimethyloxazole-4-carboxamide
   Show/Hide
C18H29N3O4
 1
1
IC50 = 45 nM
   TI
   LI
   LO
   TS
CP0462759
(3R)-6-cyclohexyl-3-[3-(2-furyl)-1,2,4-oxadiazol-5-yl]-N-hydroxyhexanamide
   Show/Hide
C18H25N3O4
 1
1
IC50 = 46 nM
   TI
   LI
   LO
   TS
CP0296747
(R)-5-(6-cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl)-N-methyl-N-((4-methylpiperazin-1-yl)methyl)-1,2,4-oxadiazole-3-carboxamide
   Show/Hide
C22H38N6O4
 1
1
IC50 = 54 nM
   TI
   LI
   LO
   TS
CP0311583
(R)-N-benzyl-5-(6-cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl)-1,2,4-oxadiazole-3-carboxamide
   Show/Hide
C22H30N4O4
 1
1
IC50 = 57 nM
   TI
   LI
   LO
   TS
CP0467265
5-(5-{(1R)-4-cyclohexyl-1-[2-(hydroxyamino)-2-oxoethyl]butyl}-1,2,4-oxadiazol-3-yl)-2-pyridinecarboxylic acid
   Show/Hide
C20H26N4O5
 1
1
IC50 = 59 nM
   TI
   LI
   LO
   TS
CP0274379
(R)-N-benzyl-5-(6-cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl)-N-methyl-1,2,4-oxadiazole-3-carboxamide
   Show/Hide
C23H32N4O4
 1
1
IC50 = 65 nM
   TI
   LI
   LO
   TS
CP0514561
(R)-2-(6-cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl)oxazole-4-carboxamide
   Show/Hide
C16H25N3O4
 1
1
IC50 = 73 nM
   TI
   LI
   LO
   TS
CP0532163
(3R)-6-cyclohexyl-N-hydroxy-3-[3-(1H-pyrazol-3-yl)-1,2,4-oxadiazol-5-yl]hexanamide
   Show/Hide
C17H25N5O3
 1
1
IC50 = 74 nM
   TI
   LI
   LO
   TS
CP0379101
(3R)-6-cyclohexyl-3-(3-{4-[(dimethylamino)sulfonyl]phenyl}-1,2,4-oxadiazol-5-yl)-Nhydroxyhexanamidehydroxyhexanamide
   Show/Hide
C21H30N4O5S
 1
1
IC50 = 75 nM
   TI
   LI
   LO
   TS
CP0428681
(3R)-6-cyclohexyl-N-hydroxy-3-(3-{[(1H-pyrazol-4-ylsulfonyl)amino]methyl}-1,2,4-oxadiazol-5-yl)hexanamide
   Show/Hide
C18H28N6O5S
 1
1
IC50 = 88 nM
   TI
   LI
   LO
   TS
CP0532162
(3R)-6-cyclohexyl-N-hydroxy-3-[3-(1-methyl-1H-imidazol-2-yl)-1,2,4-oxadiazol-5-yl]hexanamide
   Show/Hide
C18H27N5O3
 1
1
IC50 = 92 nM
   TI
   LI
   LO
   TS
CP0505532
(3R)-3-(3-{[(aminosulfonyl)amino]methyl}-1,2,4-oxadiazol-5-yl)-6-cyclohexyl-Nhydroxyhexanamide
   Show/Hide
C15H27N5O5S
 1
1
IC50 = 98 nM
   TI
   LI
   LO
   TS
CP0532160
(3R)-6-cyclohexyl-N-hydroxy-3-(3-{[(2-pyridinylsulfonyl)amino]methyl}-1,2,4-oxadiazol-5-yl)hexanamide
   Show/Hide
C20H29N5O5S
 1
1
IC50 = 107 nM
   TI
   LI
   LO
   TS
CP0428680
(3R)-6-cyclohexyl-N-hydroxy-3-(3-phenyl-1,2,4-oxadiazol-5-yl)hexanamide
   Show/Hide
C20H27N3O3
 1
1
IC50 = 116 nM
   TI
   LI
   LO
   TS
CP0462757
(3R)-6-cyclohexyl-N-hydroxy-3-[3-(aminomethyl)-1,2,4-oxadiazol-5-yl]hexanamide
   Show/Hide
C15H26N4O3
 1
1
IC50 = 122 nM
   TI
   LI
   LO
   TS
CP0335169
N-[[[(2R)-2-[(1R)-1-[formyl(hydroxy)amino]propyl]heptanoyl]amino]methyl]-7-methoxy-1-benzofuran-2-carboxamide
   Show/Hide
C22H31N3O6
 1
1
IC50 = 126 nM
   TI
   LI
   LO
   TS
CP0439784
ethyl 4-[5-[(3R)-6-cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl]-1,2,4-oxadiazol-3-yl]benzoate
   Show/Hide
C23H31N3O5
 1
1
IC50 = 154 nM
   TI
   LI
   LO
   TS
CP0238669
N-[[[(2R)-2-[[formyl(hydroxy)amino]methyl]heptanoyl]amino]methyl]-7-methoxy-1-benzofuran-2-carboxamide
   Show/Hide
C20H27N3O6
 1
1
IC50 = 160 nM
   TI
   LI
   LO
   TS
CP0238670
N-[[[(2R)-2-benzyl-3-[formyl(hydroxy)amino]propanoyl]amino]methyl]-7-methoxy-1-benzofuran-2-carboxamide
   Show/Hide
C22H23N3O6
 1
1
IC50 = 160 nM
   TI
   LI
   LO
   TS
CP0428683
ethyl 3-[5-[(3R)-6-cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl]-1,2,4-oxadiazol-3-yl]benzoate
   Show/Hide
C23H31N3O5
 1
1
IC50 = 184 nM
   TI
   LI
   LO
   TS
CP0467264
(3R)-3-(3-{[(aminocarbonyl)amino]methyl}-1,2,4-oxadiazol-5-yl)-6-cyclohexyl-Nhydroxyhexanamide
   Show/Hide
C16H27N5O4
 1
1
IC50 = 324 nM
   TI
   LI
   LO
   TS
CP0118590
(R)-2-(3-Cyclohexyl-propyl)-N*1*-[(S)-2,2-dimethyl-1-((R)-1-phenyl-ethylcarbamoyl)-propyl]-N*4*-hydroxy-succinamide
   Show/Hide
C27H43N3O4
 1
1
IC50 = 820 nM
   TI
   LI
   LO
   TS
CP0126695
N-[[[(2R)-2-[[formyl(hydroxy)amino]methyl]pentanoyl]amino]methyl]-7-methoxy-1-benzofuran-2-carboxamide
   Show/Hide
C18H23N3O6
 1
1
IC50 = 1250 nM
   TI
   LI
   LO
   TS
CP0540631
N-[[[(2S)-2-[[formyl(hydroxy)amino]methyl]heptanoyl]amino]methyl]-7-methoxy-1-benzofuran-2-carboxamide
   Show/Hide
C20H27N3O6
 1
1
IC50 = 4000 nM
   TI
   LI
   LO
   TS
CP0540630
N-[[3-[formyl(hydroxy)amino]propanoylamino]methyl]-7-methoxy-1-benzofuran-2-carboxamide
   Show/Hide
C15H17N3O6
 1
1
IC50 = 6300 nM
   TI
   LI
   LO
   TS
CP0163469
(R)-ethyl 5-(1-(hydroxyamino)-1-oxo-6-phenylhexan-3-yl)-1,2,4-oxadiazole-3-carboxylate
   Show/Hide
C17H21N3O5
 1
1
IC50 = 6600 nM
   TI
   LI
   LO
   TS
CP0056331
(R)-N'-((S)-3,3-dimethyl-1-oxo-1-((R)-1-phenylethylamino)butan-2-yl)-N4-hydroxy-2-(3-phenylpropyl)succinamide
   Show/Hide
C27H37N3O4
 1
1
IC50 = 8765 nM
   TI
   LI
   LO
   TS
CP0335168
N-[[[(2R)-2-[(1S)-1-[formyl(hydroxy)amino]propyl]heptanoyl]amino]methyl]-7-methoxy-1-benzofuran-2-carboxamide
   Show/Hide
C22H31N3O6
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0091028
(S)-5-(6-cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl)-1,2,4-oxadiazole-3-carboxamide
   Show/Hide
C15H24N4O4
 1
1
IC50 > 2000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0128115
(R)-5-(6-cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl)-N,N-dimethyl-1,2,4-oxadiazole-3-carboxamide
   Show/Hide
C17H28N4O4
 1
1 IC50 = 9.3 nM
CP0175273
3-[[4-(benzylcarbamoylamino)phenyl]sulfonyl-[2-(4-methoxyphenyl)ethyl]amino]-N-hydroxypropanamide
   Show/Hide
C26H30N4O6S
 1
1 IC50 = 10 nM
CP0052398
(3R)-6-cyclohexyl-N-hydroxy-3-(1,2,4-oxadiazol-5-yl)hexanamide
   Show/Hide
C15H24N4O4
 1
1 IC50 = 26 nM
CP0164742
N-[(4R)-4-[1,3-benzodioxol-5-ylmethyl-(4-methoxyphenyl)sulfonylamino]-5-(hydroxyamino)-5-oxopentyl]benzamide
   Show/Hide
C27H29N3O8S
 1
1 IC50 = 98 nM
CP0104223
[3-ethoxy-5-[5-[[[(2R)-2-[(1R)-1-[formyl(hydroxy)amino]propyl]heptanoyl]amino]methylcarbamoyl]furan-2-yl]phenyl]phosphonic acid
   Show/Hide
C25H36N3O9P
 1
1 Ki = 0.04 nM
CP0052399
(3R)-6-cyclohexyl-N-hydroxy-3-(3-{[(methylsulfonyl)amino]-methyl}-1,2,4-oxadiazol-5-yl)hexanamide
   Show/Hide
C16H28N4O5S
 1
1 Ki = 11 nM
Clinical Information about the Protein
Target 1 ( Bone morphogenetic protein 1 (BMP1) )
Target Type Literature-reported Target
Similar Protein(s) and Bioactivity Statistics
50% Identity
Protein ID Protein Name Protein Organism
PT06770 Tolloid-like protein 2 Homo sapiens, Human